The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 15, 2014
Filed:
Sep. 29, 2010
Toru Miura, Higashimurayama, JP;
Seiichi Sato, Higashimurayama, JP;
Hajime Yamada, Higashimurayama, JP;
Junya Tagashira, Higashimurayama, JP;
Ryohei Sekimoto, Higashimurayama, JP;
Rie Ishida, Higashimurayama, JP;
Hitomi Aoki, Higashimurayama, JP;
Tadaaki Ohgiya, Higashimurayama, JP;
Toru Miura, Higashimurayama, JP;
Seiichi Sato, Higashimurayama, JP;
Hajime Yamada, Higashimurayama, JP;
Junya Tagashira, Higashimurayama, JP;
Ryohei Sekimoto, Higashimurayama, JP;
Rie Ishida, Higashimurayama, JP;
Hitomi Aoki, Higashimurayama, JP;
Tadaaki Ohgiya, Higashimurayama, JP;
Kowa Company, Ltd., Nagoya-shi, JP;
Abstract
Disclosed are: a novel compound which has both an antagonistic activity on an angiotensin II receptor and a PPARγ-activating activity and is therefore useful as a prophylactic and/or therapeutic agent for hypertension, heart diseases, arteriosclerosis, type-2 diabetes, diabetic complications, metabolic syndrome or the like; and a pharmaceutical composition containing the compound. Specifically disclosed are: a compound represented by general formula (I) (wherein the ring A represents a pyridine ring; the ring B represents a tetrazole ring or an oxadiazol-5(4H)-one ring; X represents C—Ror a nitrogen atom; Rrepresents a Calkyl group; Rrepresents a Calkyl group or a Ccycloalkyl group; and R, R, Rindependently represent a hydrogen atom, a halogen atom, a Calkyl group, a halo-Calkyl group, or a Calkoxy group which may have a substituent), a salt of the compound, or a solvate of the compound or the salt; and a pharmaceutical composition containing the compound, the salt or the solvate.